Rooti Rx ECG Event Recorder vs Tempus ECG-AF
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Rooti Rx is a wearable ECG event recorder focused on continuous cardiac monitoring and rapid diagnostic reporting for detected events. Tempus ECG-AF, conversely, is a software algorithm that analyzes standard 12-lead ECGs to predict the risk of new-onset atrial fibrillation in older patients. While both leverage AI in cardiology, Rooti Rx provides ongoing diagnostic insights from long-term data, whereas Tempus ECG-AF offers a predictive risk assessment from a single point-in-time measurement.
Choose Rooti Rx ECG Event Recorder if…
Choose Rooti Rx if you need continuous, high-resolution ECG monitoring for up to 7 days to capture and rapidly diagnose intermittent cardiac events. It is ideal for patients experiencing symptoms, offering AI-driven interpretation and reports within 24 hours, along with mobile telemetry for real-time event marking.
View Rooti Rx ECG Event Recorder →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your objective is to proactively identify patients aged 65 or older, without pre-existing AF, who are at increased risk of developing atrial fibrillation within the next 12 months. This AI-based algorithm analyzes standard 12-lead ECGs to enable earlier identification and follow-up, supporting preventative strategies.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rooti Rx ECG Event Recorder | Tempus ECG-AF |
|---|---|---|
| Pricing | Contact for pricing | Contact vendor |
| Deployment | Cloud-based (RootiCare platform on AWS) and device-based | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rooti Rx ECG Event Recorder | Tempus ECG-AF |
|---|---|---|
| Product Name | Rooti Rx ECG Event Recorder | Tempus ECG-AF |
| Company | Rooti Labs Ltd. | Tempus AI, Inc. |
| Description | A compact, wearable ECG event recorder that, combined with the AI-powered RootiCare platform, provides continuous cardiac monitoring and rapid, accurate diagnostic reports for medical professionals. | An FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. |
| Key Functionality | Continuous cardiac monitoring and rapid, accurate diagnostic reports via wearable ECG and AI-driven interpretation. | AI-based algorithm for 12-lead ECG analysis to detect signs associated with new onset Atrial Fibrillation (AF) within 12 months for patients 65 or older. |
| Target Patient Population | Not specified | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery |
Videos
Demos, reviews, and walkthroughs featuring Rooti Rx ECG Event Recorder and Tempus ECG-AF.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Rooti Rx is a wearable ECG event recorder designed for continuous cardiac monitoring and rapid, accurate diagnostic reports for various cardiac events. In contrast, Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Rooti Rx uses its compact wearable ECG device to record single or three-channel ECG and actigraphy data for up to 7 days, which is then interpreted by its AI-driven RootiCare platform. Tempus ECG-AF analyzes existing FDA-authorized resting 12-lead ECG recordings from compatible systems like GE Medical Systems and Philips Medical Systems using its AI-based algorithm.
Rooti Rx is intended for general continuous cardiac monitoring for medical professionals across specialties like Cardiology, Family Medicine, and Internal Medicine, for patients 21 years of age or older. Tempus ECG-AF is specifically designed for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, to assess their risk of new-onset AF.
Tempus ECG-AF has established CMS reimbursement available, with CPT codes 0764T and 0765T assigned to APC 5734, and a Medicare rate of $128.90 effective January 1, 2025. Rooti Rx's pricing is custom and available upon request, but specific reimbursement codes are not mentioned in the provided information.
Rooti Rx involves a compact wearable device for data collection and a cloud-based RootiCare platform on AWS for online ECG review, editing, and report generation. Tempus ECG-AF is a software solution designed for integration into healthcare facility systems, leveraging advanced cardiology algorithms to analyze existing 12-lead ECG recordings.
Rooti Rx provides AI-driven interpretation, quality assurance checks, and fast report generation within 24 hours for continuous ECG and actigraphy recordings. Tempus ECG-AF provides an identification of patients at increased risk of developing new-onset Atrial Fibrillation (AF) within 12 months, with results interpreted in conjunction with other diagnostic information and clinical history.